Positive Outcomes of High Hemoglobin Target in Patients With Chronic Kidney Disease Not on Dialysis: A Randomized Controlled Study-Reference-Cited by-同舟云学术

Positive Outcomes of High Hemoglobin Target in Patients With Chronic Kidney Disease Not on Dialysis: A Randomized Controlled Study

Published:2011-05-25 Issue:5 Volume:15 Page:431-440
ISSN:1744-9979
Container-title:Therapeutic Apheresis and Dialysis
language:en
Short-container-title:

Author:

Akizawa Tadao,Gejyo Fumitake,Nishi Shinichi,Iino Yasuhiko,Watanabe Yuzou,Suzuki Masashi,Saito Akira,Akiba Takashi,Hirakata Hideki,Fukuhara Shunichi,Morita Satoshi,Hiroe Michiaki,Hada Yoshiyuki,Suzuki Makoto,Akaishi Makoto,Iwasaki Manabu,Tsubakihara Yoshiharu,

Publisher

Wiley

Subject

Nephrology,Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1744-9987.2011.00931.x/fullpdf

Reference24 articles.

1. Correction of anemia with epoetin alfa in chronic kidney disease;Singh;N Engl J Med,2006

2. Normalization of hemoglobin level in patients with chronic kidney disease and anemia;Drüeke;N Engl J Med,2006

3. Effect of early correction of anemia on the progression of CKD;Rossert;Am J Kidney Dis,2006

4. Anemia Correction in Diabetes Study Investigators. Target level for hemoglobin correction in patients with diabetes and CKD: primary results of the Anemia Correction in Diabetes (ACORD) Study;Ritz;Am J Kidney Dis,2007

5. Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients;Kuriyama;Nephron,1997

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anaemia and quality of life in chronic kidney disease: a consensus document from the European Anaemia of CKD Alliance;Clinical Kidney Journal;2024-07-04

2. Efficacy of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Clinical Parameters in Patients with Heart Failure;Medicina;2024-01-01

3. Efficacy and factors influencing dosage of roxadustat for erythropoietin-resistant anemia in hemodialysis patients;Nihon Toseki Igakkai Zasshi;2024

4. Anemia Treatment, Hemoglobin Variability, and Clinical Events in Patients With Nondialysis-Dependent CKD in Japan;Kidney360;2023-07-10

5. Anemia combined with albuminuria increases the risk of cardiovascular and renal events, regardless of a reduced glomerular filtration rate, in patients with type 2 diabetes: a prospective observational study;Diabetology International;2023-05-30